Takeda Pharmaceutical Co. Ltd. - Funds From Operation To Total Debt

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in Percent.

The item "Funds-From-Operation-To-Total-Debt" stands at 24.24 percent as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Funds From Operation To Total Debt" stands at 24.24 Percent. This represents an increase of 1.90 percentage points compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 8.17 percentage points compared to the value the year prior.
The 1 year change in percentage points is 8.17.
The 3 year change in percentage points is 4.65.

The Serie's long term average value is 19.73 percent. It's latest available value, on 09/30/2025, is 4.51 percentage points higher, compared to it's long term average value.
The Serie's change in percentage points from it's minimum value, on 06/30/2024, to it's latest available value, on 09/30/2025, is +10.53.
The Serie's change in percentage points from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0.